Jeil M&S Co Ltd

Jeil M&S Co Ltd exhibits a highly leveraged capital structure, with total liabilities of KRW 539.5 billion and total equity of KRW -11.5 billion, resulting in a debt-to-equity ratio of -5.97. The company's liquidity position is weak, with cash and equivalents of KRW 668.4 million and a current ratio of 0.93, indicating that current liabilities exceed current assets. The valuation snapshot shows a market cap of KRW 81.1 billion and an enterprise value to revenue ratio of 0.98, suggesting a low valuation relative to revenue. Profitability metrics are mixed, with a gross profit of KRW 8.5 billion and a return on equity of 1.37%, but the company reported an operating loss of KRW 7.7 billion and a net loss of KRW 15.7 billion, indicating significant operational challenges. The return on assets is negative at -0.03%, further highlighting inefficiencies in asset utilization. These results fall below the typical performance of the Industrial Machinery & Equipment industry, which generally expects positive operating margins and higher asset returns. The company's revenue is concentrated in the secondary battery, diffusion, food, and pharmaceutical industries, as disclosed in its business description. No specific geographic breakdown is provided, but the company is based in Korea, suggesting a regional focus. The lack of geographic diversification may expose the company to regional economic and regulatory risks. Growth trajectory is negative, with the company reporting a net loss and negative operating cash flow of KRW -31.7 billion. The outlook for the current fiscal year is likely to remain challenging, with no clear signs of improvement in the near term. The company's capital expenditure of KRW -86.3 million suggests minimal investment in growth initiatives, which may hinder future expansion. Risk factors include a high liquidity risk due to negative net cash and a current ratio below 1, as well as a credit risk from the high debt-to-equity ratio. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. The company's financial health is further complicated by the negative net income and operating income, which may affect its ability to service debt and meet obligations. Recent events and filings have not been provided in the input data, so no specific recent developments can be cited. However, the company's financial performance and risk profile suggest a need for close monitoring of its liquidity and profitability trends.